INC Research, Inc. Adds Elite Talent to Optimize Global Services Business Unit

October 26, 2010 |

2 min read

RALEIGH, NC--(Marketwire - October 26, 2010) -

Highlighted Links

INC Research, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, is pleased to welcome John Barker as executive vice president to lead its Global Services business unit. Within this post, Barker will be responsible for maintaining high-quality deliverables from the company’s range of global trial services, including Data Services, Regulatory, Drug Safety, and Functional Services.

“It is a pleasure to welcome this seasoned leader to our executive team, whose core talents will benefit our entire organization,” said John Potthoff, COO of INC Research. “John’s extensive global CRO experience will contribute significantly to serve our external and internal customers with excellence, and maintain the organization’s continued global growth.”

Barker comes to INC Research with extensive leadership and management experience within the global CRO industry. Previously, Barker served in executive leadership roles at PPD, where he had direct responsibility for quality delivery on clinical trials, as well as managing global clinical operations and corporate project management system support. He also served in senior management roles at InGenium Research as COO and at Quintiles as vice president Project Management, vice president of Investigator Site Services and Patient Recruitment, and vice president of Accelerated Clinical Research Systems. Additionally, he served as an officer in the U.S. Army.

INC Research provides full service CRO support in 40 countries worldwide, across six continents. For more information on INC Research’s Global Services, click here.

About INC Research, Inc.
INC Research is a therapeutically focused contract research organization with a high performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in therapeutic areas of specialty, and in innovative pediatric and women’s health trials. The company’s The Trusted Process® methodology and therapeutic foresight leads customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, North Carolina. For more information please visit www.incresearch.com.